Masimo Corporation
MASI
Pozycja w akcjach
#2165
Masimo Corporation engages in the development, manufacture, and marketing of... Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, and methemoglobin. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Iris, iSirona, Replica, and UniView; and brain function monitoring, hemodynamic monitoring, regional oximetry, acoustic respiration rate monitoring, capnography and gas monitoring, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.
Cena akcji
$179.95
Ostatnia synchronizacja: 2026-06-12
Kapitalizacja rynkowa
$9.42B
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
22.41%
Kraj
US
Handel Masimo Corporation (MASI)
Kategoria
Healthcare
Wskaźnik P/B dla Masimo Corporation (MASI)
Wskaźnik P/B na dzień October 2026 TTM: 11.91
Według najnowszych raportów finansowych i ceny akcji Masimo Corporation, obecny wskaźnik P/B (TTM) wynosi 11.91. Na koniec 2023 wynosił 4.53.
Historia wskaźnika P/B dla Masimo Corporation od 2002 do 2026
Wskaźnik P/B na koniec każdego roku
| Rok | Wskaźnik P/B | Zmień |
|---|---|---|
| 2026 (TTM) | 11.91 | 37.49% |
| 2024 | 8.66 | 91.05% |
| 2023 | 4.53 | -23.44% |
| 2022 | 5.92 | -43.21% |
| 2021 | 10.43 | 42.92% |
| 2019 | 7.30 | 19.54% |
| 2018 | 6.10 | 1.17% |
| 2017 | 6.03 | 1.26% |
| 2016 | 5.96 | 28.78% |
| 2015 | 4.63 | -7.67% |
| 2013 | 5.01 | 15.76% |
| 2012 | 4.33 | 7.51% |
| 2011 | 4.03 | -33.65% |
| 2010 | 6.07 | -20.40% |
| 2009 | 7.62 | -48.32% |
| 2007 | 14.75 | 146.64% |
| 2006 | 5.98 | -184.74% |
| 2005 | -7.06 | 0.00% |
| 2004 | 0.00 | -100.00% |
| 2003 | -6.18 | -13.17% |
| 2002 | -7.12 | 0.00% |
Wskaźnik P/B dla podobnych firm lub konkurentów
| Firma | Wskaźnik P/B | Różnica wskaźnika P/B | Kraj |
|---|---|---|---|
| 3.5116 | -70.51% |
US
|
|
| 2.0146 | -83.08% |
IE
|
|
| 4.5025 | -62.19% |
US
|
|
| 2.5486 | -78.60% |
US
|
|
| - | - |
DE
|
